1999
DOI: 10.1159/000028309
|View full text |Cite
|
Sign up to set email alerts
|

Reduction by ATP-Sensitive Potassium Channel Opener, YM934, of Experimental Myocardial Infarct Size in Anesthetized Dogs

Abstract: The present study was undertaken to examine whether the ATP-sensitive potassium channel opener, YM934, would be effective in reducing infarct size in a model of myocardial infarction in anesthetized dogs. For this purpose the effects of nifedipine, a calcium channel blocker, and hydralazine, a vasodilator with unknown mechanisms, were also investigated for comparison. Severe, irreversible myocardial injury was produced by a 90-min occlusion of the proximal left anterior descending coronary artery followed by 5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

1999
1999
2005
2005

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(6 citation statements)
references
References 19 publications
0
6
0
Order By: Relevance
“…YM934, a pure ATP-sensitive potassium channel opener that selectively affects mitochondrial potassium channels, 3,4,15) was confirmed to decrease the LCx peripheral vascular resistance, increase the LCx coronary flow, and improve the recovery-interval of myocardial function following transient coronary occlusion with the LCx coronary stenosed. In contrast, NTG dilated the proximal conduit artery without changing the coronary flow or improving the recovery-time of myocardial function under the same study condition.…”
Section: Discussionmentioning
confidence: 97%
See 4 more Smart Citations
“…YM934, a pure ATP-sensitive potassium channel opener that selectively affects mitochondrial potassium channels, 3,4,15) was confirmed to decrease the LCx peripheral vascular resistance, increase the LCx coronary flow, and improve the recovery-interval of myocardial function following transient coronary occlusion with the LCx coronary stenosed. In contrast, NTG dilated the proximal conduit artery without changing the coronary flow or improving the recovery-time of myocardial function under the same study condition.…”
Section: Discussionmentioning
confidence: 97%
“…We used 0.3 µg/kg of YM934 in the present experiment, based on our preliminary study and previous studies reporting the effect of this dose on hemodynamic variables. 3,4,16) Higher doses of YM934 induce dose-dependent decreases in aortic pressure. The NTG dose, 3 µg/kg/min, was confirmed not to induce hypotension.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations